Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-04-15
Original SEC Filing: Click here

---

Webplus: SVA/20190415/6-K_1/2_EX-99.1/000.htm SEC Original: tv518907_ex99-1.htm
Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an update for shareholders with regards to the exchange (the “Exchange”) of preferred share purchase rights (the “Rights”) for

---

---

Webplus: SVA/20190415/6-K_1/1/000.htm SEC Original: tv518907_6k.htm
FORM 6-K ————– ———- SINOVAC BIOTECH LTD. No. 15 Zhi Tong Road Zhongguancun Science and Technology Park Changping District Beijing 102200, People’s Republic of China Form 20-F ý Form 40-F ¨ SINOVAC BIOTECH LTD. Nan Wang 6-K 1 tv518907_6k.htm 6-K

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-04-15CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200